期刊文献+

药品技术价值与经济价值的相关性分析 被引量:4

Correlation Between the Technical Value and the Economic Value of Drugs
原文传递
导出
摘要 目的:探索药品技术价值与经济价值之间的相关性,为制药企业的产品研发和市场维护提供一定参考。方法:通过选定反映药品技术价值和经济价值的相关变量,利用SPSS统计分析软件,以美国食品与药品管理局2001年版《药品橙皮书》中的专利药品为样本,进行药品技术价值指标与经济价值指标间的χ2检验,判定其间的相关关系。结果与结论:药品技术价值与经济价值之间具有相关性,但是技术价值高的药品不一定具有较高的经济价值,新剂型药物相较新化合实体药物更容易成为畅销药。 OBJECTIVE : To study the correlation between the technical value and the economic value of drugs, and to provide references for the R&D and market maintenance. METHODS: Based on related variable which reflected technogical value and economical value of drugs, with SPSS statistical software, Chisquared test of the technical value index and the economic value index of drugs was carried out on the sample drugs published in FDA' s Drug Orange Book. RESULTS & CONCLUSIONS : A significant correlation is noted between technical value and economic value of drugs. However, the drugs with higher technical value may not possess higher economic value. And NDD tends to become best-selling drug much more easily than NCE.
出处 《中国药房》 CAS CSCD 北大核心 2011年第13期1153-1155,共3页 China Pharmacy
关键词 药品 技术价值 经济价值 相关性 Drug Technical value Economic value Correlation
  • 相关文献

参考文献11

  • 1U.S. Food and Drug Administration. Food and drug administration modernization act[EB/OL ]. http://www.fda. gov/Regulatorylnformation/Legislation/FederalFoodDrug- andCosmeticActFDCAct/SignificantAmendmentstotheFD- CAct/FDAMA/FullTextofFDAMAlaw/default.htm.2009 - 10-22.2010-11-24. 被引量:1
  • 2胡元佳,虞忠,卞鹰,王一涛.专利异议状况与药品经济价值的相关性研究[J].中国药房,2007,18(19):1449-1451. 被引量:3
  • 3曹巍,李清华,雷霆,吴乐山.国际“重磅药品”标准演变分析及我国“重磅药品”标准探析[J].中华医学科研管理杂志,2006,19(4):208-211. 被引量:1
  • 4Harhoff D, Scherer FM, Vopel K. Citations, family size, opposition and the value of patent rights[J]. Research Policy,2002, 32(2):1 343. 被引量:1
  • 5Reitzig M. Valuing patents and patent portfolios from a corporate perspective-theoretical considerations, applied needs, and future challenges[C]. Conference on intellectual assets: valuation and capitalization. Geneva: United Nations, 2003: 66-82. 被引量:1
  • 6U.S. Food and Drug Administration. Orange book[EB/OL]. http ://www.accessdata.fda.gov/scripts/cder/ob/default.cfm. 2010-10-14.2010-11-24. 被引量:1
  • 7European Patent Office. International Patent Documentation Centre[EB/OL ].http : / /www.epo.org/patents/patentin-formation/raw-data.html.2010-11-23.2010-11-24. 被引量:1
  • 8颜虹.医学统计学[M].北京:人民卫生出版社,2006.214-228. 被引量:11
  • 9Cook T. Pharmaceutical patent litigation in Europe[J]. Expert Opinion on Therapeutic Patents, 1999, 9(2) : 181. 被引量:1
  • 10医药网.海内外医药公司积极寻求药物创新的各种路径[EB/OL].http://news.pharmnet.tom.cn/news/2007/07/19/201815.html.2007-07-19.2010-11-24. 被引量:1

二级参考文献10

  • 1北京生物技术和新医药产业促进中心.启航:2004北京生物工程和新医药产业发展报告.北京:科学出版社,2004.1~35 被引量:2
  • 2北京生物技术和新医药产业促进中心.启航:2005北京生物工程和新医药产业发展报告.北京:科学出版社,2005.1~20 被引量:2
  • 3Angell M.The Truth About the Drug Companies[M].New York:Random House,2004:20~ 22. 被引量:1
  • 4Harhoff D,Scherer FM,Vopel K.Citations,family size,opposition and the value of patent rights[J].Research Policy,2002,32(2):1 343. 被引量:1
  • 5Reitzig M.Valuing patents and patent portfolios from a corporate perspective-theoretical considerations,applied needs,and future challenges[A].Conference on intellectual assets:valuation and capitalization[C].Geneva:United Nations,2003:66~ 82. 被引量:1
  • 6Reitzig M.Improving patent valuation methods for management-validating new indicators by analyzing application rationales[J].Research Policy,2004,33(6):939. 被引量:1
  • 7Lanjouw JO,Schankerman M.Patent quality and research productivity-measuring innovation with multiple indicators[J].The Economic Journal,2004,114(4):441. 被引量:1
  • 8U.S.Food and Drug Administration.Orange book[EB/OL].http://www.fda.gov/cder/orange.2006.2007,2,20. 被引量:1
  • 9European Patent Office.International Patent Documentation Centre[EB/OL].http://ep.espacenet.com.2006.2007,2,20. 被引量:1
  • 10上海医药工业研究院.中国医药数字图书馆[EB/OL].http://www.pharmadl.com.2006.2007,2,20. 被引量:1

共引文献12

同被引文献56

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部